This website is still under construction
About
LUPEX-International Ltd. is a research group that is dedicated to the development and distribution of LUPEX-Peptide M (Met-enkephalin). LUPEX-Peptide M is a synthetic peptide that has shown positive effects against viral diseases such as VHB (Virus Hepatitis B), VHC (Virus Hepatitis C) and HIV (Human Immunodeficiency Virus) amongst others.
Lupex®
Composition:
1 vial LUPEX® contains 5 mg Peptide-M, a low-molecular, short chain, synthetic peptide. It is an ubiquitous peptide present in different human and animal tissues. Peptide-M is also found in the thymus gland in low quantities.
Range of Application
- Lupus erythematosus
- multiple sclerosis
- retrobulbar neuritis
- uveitis
- various autoimmune diseases
- rheumatoid arthritis
- adenocarcinoma
- bone metastasis by mamma-carcinomas, micro cell bronchial carcinomas, prostate carcinomas and metastasis
- Kaposi's sarcoma
Contraindication:
Not known
Adverse Effects:
Vomiting could occur if the injection is given on an empty stomach.
Flush and/or dry mouth could occur also (immediately disappears after drinking some water).
Dosage:
5 mg subcutaneous daily, five times a week or 2 to 3 times a day up to a daily maximum total amount of 40 mg depending on the severity of the disease and each individual. long-term treatment: At first two injections weekly and then one for 1 or 2 years.
Administration:
Dissolve LUPEX® 5 mg in 2 ml aqua ad iniectabilia or physiological saline.
Subcutaneous application with a very thin needle.
20 mg should be dissolved in 4 ml aqua ad iniectabilia or physiological saline.
Injections should be given while the patient is lying down, and the patient should rest for at least 15 minutes after the injection.
Storage:
Store in a dry place, not over 25°C.
The prepared injection solution should be used within 3 hours.
Warning:
Peptid-M research has not been concluded yet. The manufacturer is obliged to observe and report adverse effects that occur during treatment with LUPEX®. Please report your observations. We are thankful for your contribution.
Package:
1 original package: 10 injection vials à 5 mg lyophilised Peptide-M and 10 ampoules solvent Clinical package: 100 vials à 5 mg lyophilised Peptide-M.
Literature
- Opioid Groth Factor (OGF) in Cancer Therapy (PDF 60 kb)
- 2nd European Congress of Pharmacology - Peptide-M (PDF)
- 2nd Int. Congress on Autoimmunity - Peptide-M (PDF)
- Advances in Systems Peptide-M - MET-Enkephalin Immunotherapy (PDF)
- Clinical Neuroscience - Ideggyogyaszati Szemle (PDF)
- Effects of Peptide-M (Lupex) on the Immune Response (PDF)
- Effects of Peptide-M (Lupex) on Clinical Findings (PDF)
- Effects of Peptide-M-Therapy on Aquired Immunity in Multiple Sclerosis (PDF)
- Int. Symposium Ocular Immunology and Inflammation - Peptid-M (PDF)
- Int. Journal of Thymology - Peptide-M (PDF)
- Model of MET-enkephalin Induced Attentions of the Bone Marrow Cell Proliferation (PDF)
- Ocular Immunology an Inflammation - Peptid-M (PDF)
- Peptide-M (Lupex) Immunotherapy in Multiple Sclerosis Optic Neuritis and Uveitis (PDF)
- Peptid-M (Lupex) Effects on the Immune Response (PDF)
- 1st Int. Conference on Signal Transduction - Peptide-D (PDF)
- IFCC-WorldLap99 Regulation of Gene Expression in Inflamation (PDF)
- Preiodicum Biologorum - Peptide-M (PDF)
Links
Affinity GmbH - pharmaceutical enterprise
Alchemy21 Net - pharmaceutical portal
Aprotinin - information portal
Biofactor GmbH Germany - production of Active Pharmaceutical Ingredients
Eagle Pharmaceutical d.o.o Beograd - pharmaceutical products
Fermentation Biotec GmbH - pharmaceutical products
Placenta Info - medical use of placenta
Srpski Lekar - open web platform for medical doctors
Stemcell-Therapy - AASC research and therapy center
Thymus-Therapy - information portal
Kilim Pirot - woven carpets
Niski Maturanti 1949 - class reunion
Zooloo - interiors
Zooloo - handbags